LU69253A1 - - Google Patents

Info

Publication number
LU69253A1
LU69253A1 LU69253A LU69253A LU69253A1 LU 69253 A1 LU69253 A1 LU 69253A1 LU 69253 A LU69253 A LU 69253A LU 69253 A LU69253 A LU 69253A LU 69253 A1 LU69253 A1 LU 69253A1
Authority
LU
Luxembourg
Application number
LU69253A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU69253A1 publication Critical patent/LU69253A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU69253A 1973-01-29 1974-01-28 LU69253A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7302991A FR2215416B1 (fr) 1973-01-29 1973-01-29

Publications (1)

Publication Number Publication Date
LU69253A1 true LU69253A1 (fr) 1974-09-25

Family

ID=9113975

Family Applications (1)

Application Number Title Priority Date Filing Date
LU69253A LU69253A1 (fr) 1973-01-29 1974-01-28

Country Status (12)

Country Link
US (1) US3872092A (fr)
JP (1) JPS5826359B2 (fr)
BE (1) BE810249A (fr)
CA (1) CA1037025A (fr)
CH (1) CH591515A5 (fr)
DE (1) DE2404130A1 (fr)
DK (1) DK137928B (fr)
FR (1) FR2215416B1 (fr)
GB (1) GB1424302A (fr)
IE (1) IE38805B1 (fr)
LU (1) LU69253A1 (fr)
NL (1) NL7401106A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL51468A (en) * 1976-02-23 1981-01-30 Sparamedica Ag 17 -hydroxy- -d-homosteroid derivatives,their preparation and pharmaceutical compositions containing them
DE4232521A1 (de) * 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates

Also Published As

Publication number Publication date
CH591515A5 (fr) 1977-09-30
NL7401106A (fr) 1974-07-31
FR2215416B1 (fr) 1976-09-10
IE38805B1 (en) 1978-06-07
US3872092A (en) 1975-03-18
FR2215416A1 (fr) 1974-08-23
DE2404130A1 (de) 1974-08-01
BE810249A (fr) 1974-07-29
GB1424302A (en) 1976-02-11
CA1037025A (fr) 1978-08-22
DK137928B (da) 1978-06-05
DK137928C (fr) 1978-10-30
JPS5826359B2 (ja) 1983-06-02
JPS5046655A (fr) 1975-04-25
IE38805L (en) 1974-07-29

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AR199451A1 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AU466283B2 (fr)
DK137928C (fr)
AR200885A1 (fr)
AR195948A1 (fr)
AU471461B2 (fr)
AU476873B1 (fr)
AR200256A1 (fr)
AU477824B2 (fr)
AR201432A1 (fr)
AR193950A1 (fr)
AR196382A1 (fr)
AU447540B2 (fr)
AR210729A1 (fr)